Lilly Cymbalta Diabetic Pain Launch To Piggyback On Depression Roll-Out
Executive Summary
Lilly's launch of two Cymbalta indications will highlight the utility of duloxetine in treating both emotional distress and physical pain
You may also be interested in...
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration
Cymbalta “Mood” And “Pain” Claims May Include Fibromyalgia And Anxiety
Lilly is pursuing fibromyalgia and generalized anxiety disorder indications to add to the two currently approved indications for Cymbalta